MEDRx is the world's first pharmaceutical company to accomplish dramatically increased absorbability of APIs by capitalizing on ionic liquid technology.
Transdermal drug delivery technology has been applied to developing local analgesics, anti-Alzheimer's drugs and antidepressants, since transdermal preparations have advantages of being able to improve patients’ QOL. Developing and providing transdermal preparations represent the fulfillment of unmet medical needs.
However, skin works as the barrier for human bodies to repel foreign substances. So, it is rather difficult for drugs to penetrate the skin barrier unless the drug has some penetration capability, which is influenced by the melting point, molecular weight, solubility, lipophilicity, etc.
Under the circumstances, we have applied our proprietary ILTS® technology to various drugs, including even compounds with low solubility and/or weak absorbability, such as biopharmaceuticals, etc.